Peripheral Blood Autologous CD34+ Cell Transplantation Promotes Angiogenesis With Atherosclerotic Ischemia for Elderly

NCT03098771 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Ischemic Disease

Interventions

PROCEDURE: the cell transplantation group
DRUG: the control group

Sponsor

Qingdao University